Jaguar Health Portfolio Company Napo Pharmaceuticals Provides Its Novel Crofelemer Powder To Treat Intestinal Failure From Microvillus Inclusion Disease In The EU For Compassionate Use

뉴스 본문을 불러오고 있어요.

Jaguar Health Portfolio Company Napo Pharmaceuticals Provides Its Novel Crofelemer Powder To Treat Intestinal Failure From Microvillus Inclusion Disease In The EU For Compassionate Use | 웨이프 WAPE

Jaguar Health Portfolio Company Napo Pharmaceuticals Provides Its Novel Crofelemer Powder To Treat Intestinal Failure From Microvillus Inclusion Disease In The EU For Compassionate Use

기사 요약

관련 종목

댓글 —